Moreover, the same group showed that a simultaneous inhibition of the PI3K/mTOR pathway and Mdm2-p53 complex assembly (by nutlin-3) is potentially effective in AML (Table 2) [82]. The gene discussed is PIK3CA; the disease is acute myeloid leukemia.